Microtech Announces First Human Case of Implantable Microsensor for Heart Failure
TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the treatment of heart failure. The first...
“Closing the Women’s Health Gap – Highlights of Biotropics Malaysia clinical study by Women, on Women, for Women”
SHAH ALAM, Malaysia, Dec. 30, 2024 /PRNewswire/ -- While gender parity has seen progress in recent years, the women's health gap remains significant. Women, despite comprising half of the global labor force, often face under-diagnosis and under-representation in healthcare research. Biotropics Malaysia is addressing this disparity by advancing clinical studies led by women, focused on health areas that have been...
Advanced Sterilization Technology and Picarro Partner to Streamline Process Optimization and EtO Emissions Compliance for Sterilization Facilities
New AST BOAZ EtO Reclamation System integrates with Picarro EtO Monitoring Systems to reduce EtO usage and costs while ensuring regulatory compliance SANTA CLARA, Calif., Jan. 30, 2025 /PRNewswire/ -- Picarro Inc., a global leader in gas monitoring, analytics, and services, has been selected by Advanced Sterilization Technology Inc. (AST),...
United Imaging Healthcare Releases 2024 ESG Report, Driving Sustainable Development Through Innovation
SHANGHAI, April 29, 2025 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271) has released its 2024 Environmental, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. The report outlines continued progress in sustainability, compliance, and corporate responsibility, emphasizing how the company integrates long-term social value with global business growth. In 2024, the company achieved...
2025 ASGCT | Immunofoco’s In Vivo CAR-T Technology Platform Debuts with Groundbreaking Innovations
MxV-G is a novel fusogen for lentiviral packaging that achieves higher vector titers and enhanced transduction efficiency. The detargeted MxV-G mutant abolishes native receptor binding while preserving its fusogenic activity. With various TCMs, the MxV-G mutant selectively transduced T cells, yielding CAR-T cells in mice with efficiency and anti-tumor efficacy comparable to wild-type. TCM3, our in-house developed T...
Medeologix Sets New Standard with 3-Week Lead Time for PET Heat Shrink Tubing
SAN JOSE, Calif., June 25, 2025 /PRNewswire/ -- Medeologix, a leading brand in medical device manufacturing, today announced a significant advancement in their production capabilities that slashes lead times for premium PET heat shrink tubing to just 3 weeks. This milestone is made possible by Medeologix's proprietary technology, meticulously engineered to streamline and optimize every stage of the manufacturing process....
Innovent Biologics Showcases “Dual Innovations” at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms
SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, held its Oncology R&D Day, unveiling its forward-looking strategy centered on dual innovation in next-generation immuno-oncology (IO) and...
Imugene Announces Outstanding Response Rates from the Phase 1b Trial of the Azer-cel Allogeneic CAR T in 3L+ DLBCL
Since the February update, an additional 5 patients have been dosed, resulting in 2 Complete Responses (CR) and 3 Partial Responses (PR) 75% Overall Response rate (ORR): 6 total CR and 3 PR in Phase 1b trial of azer-cel, an allogeneic off-the-shelf CD19 CAR T therapy in relapsed diffuse large B-cell lymphoma (DLBCL), an aggressive type of blood...
Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Clinical study in Scientific Reports shows Bridge Capture™ detects key mutations from blood samples in metastatic colorectal cancer patients TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published in Scientific Reports,...
Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /PRNewswire/ -- Berlin Heals, a pioneer in bioelectric medicine for the treatment of heart failure, is pleased to announce the publication of a new peer-reviewed study titled "Two-year outcomes of a cardiac microcurrent...
